United Therapeutics Corporation Current State and Local Tax Expense (Benefit)
United Therapeutics Corporation (UTHR) reported Current State and Local Tax Expense (Benefit) of $71.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-25
- United Therapeutics Corporation current state and local tax expense (benefit) for fiscal 2025 was $71.50M, a 11.51% decline from fiscal 2024.
- United Therapeutics Corporation current state and local tax expense (benefit) for fiscal 2024 was $80.80M, a 21.32% increase from fiscal 2023.
- United Therapeutics Corporation current state and local tax expense (benefit) for fiscal 2023 was $66.60M, a 45.41% increase from fiscal 2022.
- United Therapeutics Corporation current state and local tax expense (benefit) for fiscal 2022 was $45.80M, a 86.18% increase from fiscal 2021.
| Period end | Current State and Local Tax Expense (Benefit) 12 month | Current State and Local Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $71.50M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $80.80M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $66.60M 10-K · filed 2026-02-25 | |
| 2022-12-31 | $45.80M 10-K · filed 2025-02-26 | |
| 2021-12-31 | $24.60M 10-K · filed 2024-02-21 | |
| 2020-12-31 | $20.00M 10-K · filed 2023-02-22 | |
| 2019-12-31 | $9.40M 10-K · filed 2022-02-24 | |
| 2018-12-31 | $17.40M 10-K · filed 2021-02-24 | |
| 2017-12-31 | $23.90M 10-K · filed 2020-02-26 | |
| 2016-12-31 | $24.10M 10-K · filed 2019-02-27 | |
| 2015-12-31 | $37.00M 10-K · filed 2018-02-21 | $33.98M 10-K · filed 2016-02-25 |
| 2014-12-31 | $21.40M 10-K · filed 2017-02-22 | $19.05M 10-K · filed 2015-02-24 |
| 2013-12-31 | $20.10M 10-K · filed 2016-02-25 | |
| 2012-12-31 | $13.95M 10-K · filed 2015-02-24 | |
| 2011-12-31 | $8.95M 10-K · filed 2014-02-25 | |
| 2010-12-31 | $1.79M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $2.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |